Suppr超能文献

生存研究中双重抽样设计的必要性:在监测总统艾滋病紧急救援计划中的应用

The need for double-sampling designs in survival studies: an application to monitor PEPFAR.

作者信息

An Ming-Wen, Frangakis Constantine E, Musick Beverly S, Yiannoutsos Constantin T

机构信息

Department of Biostatistics, Johns Hopkins University, Baltimore, Maryland 21205, USA.

出版信息

Biometrics. 2009 Mar;65(1):301-6. doi: 10.1111/j.1541-0420.2008.01043.x. Epub 2008 May 13.

Abstract

In 2007, there were 33.2 million people around the world living with HIV/AIDS (UNAIDS/WHO, 2007). In May 2003, the U.S. President announced a global program, known as the President's Emergency Plan for AIDS Relief (PEPFAR), to address this epidemic. We seek to estimate patient mortality in PEPFAR in an effort to monitor and evaluate this program. This effort, however, is hampered by loss to follow-up that occurs at very high rates. As a consequence, standard survival data and analysis on observed nondropout data are generally biased, and provide no objective evidence to correct the potential bias. In this article, we apply double-sampling designs and methodology to PEPFAR data, and we obtain substantially different and more plausible estimates compared with standard methods (1-year mortality estimate of 9.6% compared to 1.7%). The results indicate that a double-sampling design is critical in providing objective evidence of possible nonignorable dropout and, thus, in obtaining accurate data in PEPFAR. Moreover, we show the need for appropriate analysis methods coupled with double-sampling designs.

摘要

2007年,全球有3320万人感染艾滋病毒/艾滋病(联合国艾滋病规划署/世界卫生组织,2007年)。2003年5月,美国总统宣布了一项全球计划,即总统艾滋病紧急救援计划(PEPFAR),以应对这一流行病。我们试图估算PEPFAR中的患者死亡率,以便对该计划进行监测和评估。然而,这一努力受到高失访率的阻碍。因此,标准生存数据以及对观察到的未退出数据的分析通常存在偏差,并且无法提供纠正潜在偏差的客观证据。在本文中,我们将双重抽样设计和方法应用于PEPFAR数据,与标准方法相比,我们获得了截然不同且更合理的估计值(1年死亡率估计值为9.6%,而标准方法为1.7%)。结果表明,双重抽样设计对于提供可能不可忽略的失访的客观证据至关重要,从而对于在PEPFAR中获得准确数据也至关重要。此外,我们表明需要结合双重抽样设计采用适当的分析方法。

相似文献

1
The need for double-sampling designs in survival studies: an application to monitor PEPFAR.
Biometrics. 2009 Mar;65(1):301-6. doi: 10.1111/j.1541-0420.2008.01043.x. Epub 2008 May 13.
3
The impact of the US president's emergency plan for AIDS relief (PEPFAR) HIV and AIDS program on the Nigerian health system.
Pan Afr Med J. 2016 Nov 11;25:143. doi: 10.11604/pamj.2016.25.143.9987. eCollection 2016.
4
Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
Sex Transm Infect. 2015 Dec;91(8):615-20. doi: 10.1136/sextrans-2014-051991. Epub 2015 Jun 8.
6
An evaluation of the President's Emergency Plan for AIDS Relief effect on health systems strengthening in sub-Saharan Africa.
J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):471-9. doi: 10.1097/QAI.0b013e3182816a86.
7

引用本文的文献

2
A semiparametric method for the analysis of outcomes during a gap in HIV care under incomplete outcome ascertainment.
Stat Commun Infect Dis. 2020 Sep;12(Suppl 1). doi: 10.1515/scid-2019-0013. Epub 2020 Nov 11.
5
HIV-associated mortality in the era of antiretroviral therapy scale-up - Nairobi, Kenya, 2015.
PLoS One. 2017 Aug 2;12(8):e0181837. doi: 10.1371/journal.pone.0181837. eCollection 2017.
7
Marginal and Conditional Distribution Estimation from Double-Sampled Semi-Competing Risks Data.
Scand Stat Theory Appl. 2015 Mar 1;42(1):87-103. doi: 10.1111/sjos.12096.
8
A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment.
J Int AIDS Soc. 2015 Dec 16;18(1):20628. doi: 10.7448/IAS.18.1.20628. eCollection 2015.

本文引用的文献

1
Responding to the HIV pandemic: the power of an academic medical partnership.
Acad Med. 2007 Aug;82(8):812-8. doi: 10.1097/ACM.0b013e3180cc29f1.
2
HIV viral dynamic models with dropouts and missing covariates.
Stat Med. 2007 Jul 30;26(17):3342-57. doi: 10.1002/sim.2816.
5
Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.
Trop Med Int Health. 2005 May;10(5):464-70. doi: 10.1111/j.1365-3156.2005.01409.x.
6
Impact of missing data due to selective dropouts in cohort studies and clinical trials.
Epidemiology. 2002 May;13(3):347-55. doi: 10.1097/00001648-200205000-00017.
7
Inference in randomized studies with informative censoring and discrete time-to-event endpoints.
Biometrics. 2001 Jun;57(2):404-13. doi: 10.1111/j.0006-341x.2001.00404.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验